“We are particularly pleased to reach this milestone that confirms our pioneering position in the digitalisation of drug delivery devices and will contribute to achieve our growth objectives”, commented Eric Dessertenne, Chief Operating Officer of BIOCORP.
Easylog is a smart sensor that turns all classic pen injectors, disposable and reusable, into connected devices. Easylog captures key treatment information (dose, date, time) and transfers it to a monitoring mobile app. This innovative solution goes hand in hand with a dedicated application that aims to facilitate the life of patients monitoring their treatment.
CE marking has been received for a version compatible with insulin delivery devices. Market launch is planned for 2018 through partnerships. These partnerships may be subject to further communication.